| 000 | 02022cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030836.0 | ||
| 008 | 130529s2010 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.19.05.Ph.D.2010.Ma.R | ||
| 100 | 0 | _aMaha Mohamed Hussanien Ibrahim | |
| 245 | 1 | 0 |
_aRisk adapted therapy for pediatric acute non-lymphoblastic leukemia at the NCI Egypt and the relation of residual disease to prognostic markers / _cMaha Mohamed Hussanien Ibrahim ; Supervised Salah Saleh Abdelhadi , Alaa Mohamed Elhaddad , Heba Mohamed Hamed Shaker |
| 246 | 1 | 5 | _aتأثير البقايا المرضية القليلة فى طرق علاج الاطفال المصابين بسرطان الدم غير الليمفاوي الحاد فى المعهد القومى للأورام |
| 260 |
_aCairo : _bMaha Mohamed Hussanien Ibrahim , _c2010 |
||
| 300 |
_a112 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Pediatric Oncology | ||
| 520 | _aTo study the impact of risk adapted approach on the prognosis of pediatric ANLL at the NCI Egypt through: A) Identifying the role of high dose intensification chemotherapy in patients showing favorable prognostic criteria and studying its effect on survival following remission induction. B) Comparing bone marrow transplantation versus high dose intensification chemotherapy in patients showing unfavorable prognostic criteria and studying its effect on survival following remission induction | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aLeukemia | |
| 653 | 4 | _aNon-lymphoblastic | |
| 653 | 4 | _aPrognostic markers | |
| 700 | 0 |
_aAlaa Mohamed Elhaddad , _eSupervisor |
|
| 700 | 0 |
_aHeba Mohamed Hamed Shaker , _eSupervisor |
|
| 700 | 0 |
_aSalah Saleh Abdelhadi , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c43071 _d43071 |
||